Lab guide · Melanocortin & kisspeptin analogues
What Is Melanotan II? Cyclic Melanocortin Peptide Research Overview
What is Melanotan II? It is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone (α-MSH), Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, that activates several melanocortin receptors. This guide covers its design, receptor profile, research history and how it relates to PT-141, which differs only at the C-terminus.
Key takeaways
- Melanotan II (MT-II) is a cyclic lactam heptapeptide, formula C50H69N15O9, molecular weight 1024.2 g/mol, CAS 121062-08-6, built from residues 4-10 of α-MSH.
- It was designed at the University of Arizona by Hadley, Hruby and colleagues as a stable, potent α-MSH analogue.
- PT-141 (bremelanotide) has the same cyclic core but a free C-terminal acid instead of an amide, a one-dalton difference.
- MT-II is a non-selective melanocortin agonist, and no medicine containing it was found in the sources reviewed.
What is Melanotan II?
So, what is Melanotan II? Melanotan II (MT-II) is a synthetic, cyclic analogue of the peptide hormone α-MSH. Its structure, Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, is recorded in PubChem. It is a non-selective melanocortin receptor agonist, studied in pigmentation biology, energy balance and central melanocortin signalling.
Research use only. This overview summarises published laboratory and animal research. Baltic Peptides supplies this compound for in-vitro and preclinical research by qualified researchers; it is not a medicine and is not for human or veterinary use.
Chemical structure and specifications
| Property | Value |
|---|---|
| Sequence | Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2 |
| Length | 7 residues; lactam bridge between Asp and Lys side chains |
| Molecular formula | C50H69N15O9 |
| Molecular weight | 1024.2 g/mol (average); 1023.540 Da monoisotopic, calculated |
| CAS number | 121062-08-6 |
| PubChem CID | 92432 |
The values match the PubChem record, and I confirmed that the sequence, with the lactam ring closure, reproduces the formula and mass. The lactam is an amide bond between two side chains, not a disulfide, so thiol reagents do not reduce it. The His-Phe-Arg-Trp core is the shared pharmacophore of melanocortin agonists, and the D-phenylalanine and norleucine substitutions are design features for potency and stability.
Discovery and research history
Melanotan II was developed at the University of Arizona by Victor Hruby, Mac Hadley and colleagues as part of a search for stable, potent α-MSH analogues. Hadley et al. (1998) review the discovery and development of Melanotan-I and Melanotan-II as melanogenic compounds.
Early human work consisted of pilot studies, including a phase I study of its pigmentation effects (Dorr et al., 1996) and a small crossover study of erectile responses (Wessells et al., 1998). A 2000 review discusses that experience, which preceded the development of the related compound PT-141 (What is PT-141).
Mechanism: melanocortin receptor agonism
Receptor profile
MT-II is a non-selective agonist at several of the five melanocortin receptors, including MC1R, MC3R, MC4R and MC5R. These are Gs-coupled receptors whose activation raises cAMP. MC1R drives pigment synthesis in melanocytes, while MC3R and MC4R in the brain are linked to energy balance and sexual behaviour in model systems.
Why selectivity matters
Because one molecule activates several receptors, an observed effect cannot be assigned to a single receptor without selective antagonists or knockout models. That is a recurring limit in interpreting MT-II studies.
Main research areas
- Pigmentation biology: MC1R signalling, cAMP and melanin synthesis in melanocytes.
- Energy balance: MC3R and MC4R regulation of feeding in rodent models.
- Behavioural models: MC4R-linked sexual behaviour in animals.
- Structure-activity work: cyclisation and substitution as tools in designing more selective ligands.
What published studies actually show
| Evidence type | What is reported |
|---|---|
| Chemical facts | Sequence, formula, mass and CAS number are database-verifiable. |
| Cell and animal studies | Melanocortin receptor activation with high potency; pigmentary, feeding and behavioural readouts in rodents. |
| Early human studies | Small pilot studies in the 1990s, including a phase I study and a small crossover study. |
| Unconfirmed | Receptor-specific attribution of effects, long-term safety, and any effect outside experimental settings. |
These human studies were small and early, and no licensed medicine containing Melanotan II was found in the sources reviewed.
Scientific limitations and open questions
- Non-selective receptor activation makes mechanistic attribution difficult.
- The human studies are small and early, with no long-term data.
- No marketing authorisation for MT-II was found in the sources reviewed.
- The tryptophan residue is light-sensitive, which is relevant to storage.
Analytical and laboratory considerations
Mass spectrometry should show the cyclic peptide at about 1024.2 Da. The linear (ring-opened) form would be 18 Da heavier, so mass distinguishes closed from open forms, and tryptophan oxidation adds 16 Da. PT-141 differs by one dalton (1025.2 Da), so the two are separable by mass and by HPLC. HPLC should also resolve the D-Phe diastereomer, which has the same mass.
See how to store peptides and the guide to reading a peptide COA. Batch reports are on the COA page, and formats are on the Melanotan 2 product page.
Sources and further reading
- PubChem compound record for melanotan-II (CID 92432). PubChem
- Hadley M.E. et al. (1998). Discovery and development of novel melanogenic drugs. Melanotan-I and -II. Pharm Biotechnol 11:575-595. PubMed
- Wessells H. et al. (1998). Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study. J Urol 160(2):389-393. PubMed
- Wessells H. et al. (2000). Melanocortin receptor agonists, penile erection, and sexual motivation. PubMed
All Baltic Peptides products are supplied strictly for laboratory research use. They are not medicines, supplements or food and are not for human or animal use. This article summarises published research for educational purposes only and does not describe any use in people.
FAQ
Common questions
What is Melanotan II?
What is the molecular weight and CAS number of Melanotan II?
What does the lactam bridge in Melanotan II do?
Who developed Melanotan II?
Which receptors does Melanotan II act on?
How is Melanotan II different from PT-141?
Is Melanotan II an approved medicine?
Keep reading
Related reading
Melanotan 2
Current batches, formats and the COA for Melanotan 2.
What is PT-141?
The free-acid analogue with the same cyclic core.
What is KPV?
A short α-MSH fragment studied separately from pigmentation.
Research-grade Melanotan II, tested before it ships
Independent HPLC and mass spec results for every batch, dispatched from the EU.
